Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDLakeShore Biopharma Co., Ltd Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.80 | -$0.80 | -$0.80 |
| Q2 2024 | 1 | -$0.80 | -$0.80 | -$0.80 |
| Q3 2024 | 1 | -$0.94 | -$0.94 | -$0.94 |
| Q4 2024 | 1 | -$0.94 | -$0.94 | -$0.94 |
| Q5 2024 | 1 | -$0.78 | -$0.78 | -$0.78 |
| Q6 2024 | 1 | -$0.78 | -$0.78 | -$0.78 |
| Q7 2024 | 1 | -$0.59 | -$0.59 | -$0.59 |
| Q1 2025 | 1 | -$0.16 | -$0.16 | -$0.16 |
LakeShore Biopharma Co., Ltd Earnings Date And Information
LakeShore Biopharma Co., Ltd last posted its earnings results on Tuesday, September 24th, 2024. The company reported $-1.34 earnings per share for the quarter, missing analysts' consensus estimates of $-0.58 by $0.76. The company had revenue of 135.53 M for the quarter and had revenue of 573.42 M for the year. LakeShore Biopharma Co., Ltd has generated $-4 earnings per share over the last year ($-4.05 diluted earnings per share) and currently has a price-to-earnings ratio of -0.74. LakeShore Biopharma Co., Ltd has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, December 19th, 2024 based on prior year's report dates.
LakeShore Biopharma Co., Ltd Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/29/2024 | Q4 2024 | -$1.72 | $21.88 M | $135.53 M | ||
| 12/29/2023 | Q3 2024 | -$0.85 | $20.11 M | $168.71 M | ||
| 09/29/2023 | Q2 2024 | -$1.13 | $96.82 M | |||
| 06/29/2023 | Q1 2024 | -$0.75 | $176.27 M | |||
| 03/30/2023 | Q4 2023 | -$13.20 | $106.12 M | |||
| 12/30/2022 | Q3 2023 | -$0.82 | $180.46 M | |||
| 09/29/2022 | Q2 2023 | $0.14 | $194.79 M | |||
| 06/28/2022 | Q1 2023 | $0.45 | $0 | |||
| 03/29/2022 | Q4 2022 | $1.78 | $0 | |||
| 12/29/2021 | Q3 2022 | $0.70 | $0 | |||
| 09/28/2021 | Q2 2022 | $0.23 | $0 | |||
| 06/28/2021 | Q1 2022 | -$1.03 | $0 |
LakeShore Biopharma Co., Ltd Earnings: FAQ's
When is LakeShore Biopharma Co., Ltd's earnings date?
LakeShore Biopharma Co., Ltd has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, December 19th, 2024 based off last year's report dates.
How can I listen to LakeShore Biopharma Co., Ltd's earnings conference
call?
The conference call for LakeShore Biopharma Co., Ltd's latest earnings report can be listened to online.
How can I read LakeShore Biopharma Co., Ltd's conference call transcript?
The conference call transcript for LakeShore Biopharma Co., Ltd's latest earnings report can be read online.
How much revenue does LakeShore Biopharma Co., Ltd generate each year?
LakeShore Biopharma Co., Ltd (:LSB) has a recorded annual revenue of $573.42 M.
How much profit does LakeShore Biopharma Co., Ltd generate each year?
LakeShore Biopharma Co., Ltd (:LSB) has a recorded net income of $573.42 M. LakeShore Biopharma Co., Ltd has generated $-4.05 earnings per share over the last four quarters.
What is LakeShore Biopharma Co., Ltd's price-to-earnings ratio?
LakeShore Biopharma Co., Ltd (:LSB) has a price-to-earnings ratio of -0.74 and price/earnings-to-growth ratio is -0.01.